poisar

Stock

Heartbeam, Inc. BEAT

$0.51-5.87%

Overview

BEAT market data

Price History

BEAT price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.62
Diluted earnings per share over the trailing twelve months.
Beta
-0.69
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.51 – $4.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $30.9 · P/B 31.76.

Company news

10 captured
Maxim Group Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2Benzinga · Jul 14, 2026, 4:19 PM
HeartBeam Wins U.S. Patent Expanding ECG Device With Acoustic Sensing, Impedance Features For Heart Disease MonitoringBenzinga · Jul 14, 2026, 11:13 AM
HeartBeam Completed Enrollment In Heart Attack Detection Pilot Study Ahead Of ScheduleBenzinga · Jun 30, 2026, 11:10 AM
HeartBeam Announces Reorganization To Prioritize Global Market Reach And Capital Efficiency While Accelerating Execution; To License Its 3D ECG Signal Technology To Established PartnersBenzinga · Jun 24, 2026, 8:15 PM
HeartBeam Announces New Peer-Reviewed JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain PatientsBenzinga · Jun 2, 2026, 11:20 AM
HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5Benzinga · May 22, 2026, 11:05 AM
Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5Benzinga · May 15, 2026, 12:45 PM
HeartBeam Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 13, 2026, 9:35 PM
HeartBeam Q1 EPS $(0.12) Beats $(0.14) EstimateBenzinga · May 13, 2026, 8:02 PM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock